Breast cancer management with CDK4/6 inhibitors as first line treatment: a single institution retrospective review. (November 2022) - Villa, F.; Corbetta, C.; Crippa, A.; Pelizzoni, D.; Vittimberga, I.; Sansi, C.; Arnoffi, J.; Guida, F.M.; Cuomo, O.; Tafuni, M.; Sassone, M.C.; Viganò, C.V.; et al.